Use of the prescription heartburn drugs such as Prevacid, Prilosec, and Nexium have been linked to short-term kidney problems, such as acute kidney injury and an inflammatory kidney disease called acute interstitial nephritis.
Studies now show a link between the drugs and chronic kidney disease, in which the kidneys lose their ability to filter blood effectively.
Over time, chronic kidney disease can lead to kidney failure, forcing someone to undergo regular dialysis and possibly a kidney transplant, according to the U.S. National Institutes of Health.
These Proton Pump Inhibitors(PPIs) such as Prevacid, Prilosec, and Nexium may increase the risk of chronic kidney failure. If you or a loved one suffered kidney failure or have been diagnosed with chronic kidney disease after daily use of the prescription strength Prilosec or Nexium, or over the counter Prilosec or Nexium (Brand name only) you may be eligible for compensation through the Nexium and Prevacid Recall.
What you need to know about the Nexium Recall and Prevacid Recall
Proton Pump Inhibitors, like Prevacid work by blocking acid release into the stomach. They are used to treat gastroesophageal reflux disease (GERD) which may occur in up to 60 percent of the adult population each year. They are also used to treat peptic ulcer disease (PUD) and a number of other stomach conditions such as “heartburn”.
The PPI market is said to be worth upwards of $10 billion annually in the U.S. alone and Nexium (esomeprazole) was the best selling prescription medication in 2012 and number two on the same list in 2013 with annual revenue of nearly $6 billion.
Up to 14 percent of U.S. adults have received prescription PPI medications and all three of the most popular PPIs are now available over-the-counter. Some estimates show that at least 25% of long-term PPI users could discontinue the medications with no adverse events and that many had started taking them with no clear indication.
People who use proton pump inhibitors (PPIs) have a 20 percent to 50 percent higher risk of chronic kidney disease compared with nonusers, said lead author Dr. Morgan Grams, an assistant professor of epidemiology at Johns Hopkins University in Baltimore.
The February 2016 issue of JAMA, the Journal of the American Medical Association, published results of a study which indicated that long-term use of PPI medications may increase the risk of the development of chronic kidney disease (CKD).
The study indicated that the 10-year risk of CKD in PPI users was 20 to 50 percent higher than those who had not taken the medications. The study also showed that the longer a person takes the medications, the greater the risk and patients who took the medications more than once a day were more likely to develop the condition.
Nexium Recall and Prevacid Recal lawsuits claim that the maker of the drug failed to disclose known side effects and risks, including chronic kidney disease.
Failure to warn patients of potential side effects can be a basis of drug company liability, regardless of whether a drug has been recalled. Affected patients and their families may be eligible to file a lawsuit.
How to get help with the Nexium Recall and Prevacid Recall
If you have been diagnosed with chronic kidney disease, acute kidney injury, interstitial nephritis, or end-stage renal disease after taking PPIs such as Nexium, Prilosec, or Prevacid, we would like to hear from you. Send us your contact information using the form on this page, and we will help you understand your rights and if you are entitled to compensation. This is a totally free service, with no hidden costs.
You May Be Entitled To Compensation. To receive a quick evaluation of your case at no cost to you, please contact us using the web form on this page. Consultation is free, and totally discreet.
Are you affected by this defect? Tell us your story.
A type of heartburn medication called proton pump inhibitors may be linked to long-term kidney damage, a new study suggests. Prilosec, Nexium and Prevacid belong to this class of drugs, which treat heartburn and acid reflux by lowering the amount of acid produced by the stomach.